Clinical Outcomes Associated With Respiratory Virus Detection Before Allogeneic Hematopoietic Stem Cell Transplant | Zendy

Angela P. Campbell | Zendy; Katherine A. Guthrie | Zendy; Janet A. Englund | Zendy; Robert M. Farney | Zendy; Elisa L. Minerich | Zendy; Jane Kuypers | Zendy; Lawrence Corey | Zendy; Michael Boeckh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Outcomes Associated With Respiratory Virus Detection Before Allogeneic Hematopoietic Stem Cell Transplant

Author(s) -

Angela P. Campbell,

Katherine A. Guthrie,

Janet A. Englund,

Robert M. Farney,

Elisa L. Minerich,

Jane Kuypers,

Lawrence Corey,

Michael Boeckh

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ272

Subject(s) - rhinovirus , medicine , human bocavirus , human metapneumovirus , respiratory system , hematopoietic stem cell transplantation , hazard ratio , pneumonia , virus , immunology , gastroenterology , confidence interval , virology , transplantation , respiratory tract infections

The management of respiratory virus infections prior to hematopoietic cell transplant (HCT) is difficult. We examined whether respiratory virus detection before HCT influenced the requirement for bronchoscopy, hospitalization, and overall survival following HCT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research